BiotechTube
MyBiotech

MyBiotech

Munich, Germany· Est.
mybiotech.de
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

MyBiotech is a specialized nanomedicine CDMO based in Munich, offering integrated services from early-stage R&D through GMP clinical manufacturing. Its core expertise lies in scaling complex nanoparticle processes, utilizing both top-down and bottom-up engineering, and providing regulatory CMC support for global filings. The company positions itself as a unified partner to accelerate nanomedicine candidates from the molecule stage into clinical trials.

MicrobiomeInfectious Disease

Technology Platform

Integrated nanomedicine CDMO platform featuring top-down and bottom-up nanoparticle engineering, advanced microreactor technology for continuous manufacturing, scalable process development, and in-house aseptic fill-finish including lyophilization.

Opportunities

The growing nanomedicine market and biotech's reliance on outsourcing create strong demand for specialized CDMO services.
MyBiotech's integrated, end-to-end model from formulation to fill-finish is a key differentiator that can accelerate client timelines and capture significant value.

Risk Factors

Revenue is project-based and susceptible to client pipeline failures or biotech funding downturns.
The company faces execution risk in scaling complex nanomedicines and intense competition from both large CDMOs and other niche players.

Competitive Landscape

MyBiotech competes with large, diversified CDMOs (e.g., Lonza, Catalent) that have nanomedicine capabilities and with smaller, specialized CROs/CDMOs in the nanoparticle space. Its key competitive advantages are its dedicated focus, integrated service stack, and expertise in advanced manufacturing techniques like continuous processing.

More companies in Drug Delivery & Formulation →More companies in Germany →